Clinical-stage pre-IPO biotech company is leveraging translational science to extend the healthy lives of beloved companions; this offering is limited to accredited investors. BOSTON, Sept. 19, 2024 /PRNewswire/ — CureLab Veterinary Inc., a pioneer in developing innovative veterinary…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.